# Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors

> **NCT00049023** · PHASE1 · COMPLETED · sponsor: **O'Dorisio, M S** · enrollment: 27 (actual)

## Conditions studied

- Brain and Central Nervous System Tumors
- Gastrointestinal Carcinoid Tumor
- Islet Cell Tumor
- Neuroblastoma
- Pheochromocytoma
- Sarcoma
- Unspecified Childhood Solid Tumor, Protocol Specific

## Interventions

- **RADIATION:** 90Y-DOTA-tyr3-OCTREOTIDE

## Key facts

- **NCT ID:** NCT00049023
- **Lead sponsor:** O'Dorisio, M S
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-01
- **Primary completion:** 2011-08
- **Final completion:** 2011-08
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2016-06-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00049023

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00049023, "Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00049023. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*